To ensure that substandard and fake medicines are denied entry into Nigeria using National Agency for Food and Drug Administration and Control (NAFDAC)-appointed Pre-Shipment agents, the agency has appointed a new global testing and inspection agency, Cotecna Inspection Services (CIS), as part of efforts to bolster its Clean Report of Inspection and Analysis (CRIA) Scheme.
The Director General of NAFDAC, Prof. Mojisola Adeyeye, disclosed this during a hybrid technical meeting on mitigating substandard and counterfeit products held in Lagos. She explained that the appointment of Cotecna was in addition to existing CRIA agents operating in India and China and was aimed at ensuring that only safe, high-quality products are shipped to Nigeria.
   
Adeyeye said the move follows the agency’s widely praised seizure, evacuation, and destruction of over ₦1 trillion worth of substandard, expired, and banned medicines from open drug markets in Idumota, Onitsha, and Aba. 

She noted that NAFDAC is strengthening the CRIA scheme to curb the influx of falsified medicines, which she described as a growing international criminal activity with serious consequences for public health and the economy.
     
According to the DG, the CRIA Scheme plays a key role in screening regulated products before they are exported to Nigeria. She stated that CRIA agents are responsible for physical inspection, product-specific testing, and verifying regulatory documents to ensure compliance with NAFDAC’s standards. She added that designated laboratories in both China and India are used to test randomly sampled products.

[Guardian]